Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acelyrin
Acelyrin
(SLRN)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Izokibep
healthy volunteers/patients
,
psoriasis
,
uveitis
,
ankylosing spondylitis
,
panuveitis
,
hidradenitis
,
psoriatic arthritis
,
arthritis
,
hidradenitis suppurativa
Bos taurus adrenal cortex corticosteroids
healthy volunteers/patients
,
breast neoplasms
,
renal cell carcinoma
,
brain neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
kidney neoplasms
,
atopic dermatitis
,
eczema
,
dermatitis
,
immune system diseases
,
inflammation
,
bronchial diseases
,
hypersensitivity
,
immediate hypersensitivity
,
respiratory hypersensitivity
,
dyspnea
,
colorectal neoplasms
,
nasal polyps
,
gastroesophageal reflux
,
bullous pemphigoid
,
churg-strauss syndrome
,
nasopharyngeal neoplasms
,
eosinophilic esophagitis
,
peptic esophagitis
,
esophagitis
,
asthma
,
chronic obstructive pulmonary disease
,
obstructive lung diseases
,
lung diseases
,
systemic lupus erythematosus
,
pulmonary eosinophilia
,
respiratory tract diseases
,
eosinophilia
,
respiration disorders
,
emphysema
,
respiratory sounds
,
disease progression
,
allergic rhinitis
,
rhinitis
,
allergic rhinitis perennial
,
hypercholesterolemia
,
metabolic bone diseases
,
osteoporosis
,
bone fractures
,
osteoporotic fractures
Solumedrol
cataract
,
postoperative pain
,
vitreoretinal surgery
,
cataract extraction
,
glaucoma
,
macular edema
,
retinal vein occlusion
,
macular degeneration
,
inflammation
,
retinal detachment
,
refractive surgical procedures
,
patient preference
,
keratoconus
,
pterygium
,
dry eye syndromes
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use